Oblique Therapeutics, a biotechnology company focused on new antibody medicines for severe diseases, has announced Christer Nordstedt as CEO. Nordstedt will assume the position on December 1, 2022. Nordstedt has…
Oblique Therapeutics, a biotechnology company focused on new antibody medicines for severe diseases, has announced Christer Nordstedt as CEO. Nordstedt will assume the position on December 1, 2022. Nordstedt has…
…
Rankings & Reports
M&A
Equity
Healthcare Investing Review
Healthcare Real Assets Report
Resources & Events
Resource Hub
Sector Events
Private Capital Conference
Real Assets Conference


